Nov 302016
 
Map: Australian Dept. For. Affairs & Trade

Map: Australian Dept. For. Affairs & Trade

Joint letter from 316 civil society groups based in countries negotiating RCEP [Printable PDF]

Dear Trade Ministers & Negotiators from the RCEP countries: This is an urgent call by 316 civil society organisations from across the Asian and Pacific countries negotiating the Regional Comprehensive Economic Partnership (RCEP), which includes the 10 ASEAN Member States with China, Japan, South Korea, India, Australia and New Zealand.

This letter comes at a very important political moment, when in the aftermath of the US elections it seems clear that the Trans-Pacific Partnership Agreement (TPP) will not be ratified by the USA, in spite of its big push since February 2016 when the agreement was signed by the 12 countries. Continue reading »

Share

The Trans Pacific Partnership Agreement and Access to HIV Treatment in Vietnam

 Posted by on November 9, 2016  Comments Off on The Trans Pacific Partnership Agreement and Access to HIV Treatment in Vietnam
Nov 092016
 
Image: EFF (CC-BY)

Image: EFF (CC-BY)

Authors: Hazel Moir, Brigitte Tenni, Deborah Gleeson & Ruth Lopert

Abstract: In the Trans Pacific Partnership (TPP) Agreement negotiations, the USA successfully pursued intellectual property (IP) provisions that will affect the affordability of medicines, including anti-retrovirals (ARV) for HIV. Vietnam has the lowest GDP per capita of the 12 TPP countries and in 2013 provided ARVs for only 68% of eligible people living with HIV. Using the current Vietnamese IP regime as our base case, we analysed the potential impact of a regime making full use of legal IP flexibilities, and one based on the IP provisions of the final, agreed TPP text. Continue reading »

Share

Australia Should Reject U.S. Push for Even Longer TPP Medicine Monopolies

 Posted by on November 6, 2016  Comments Off on Australia Should Reject U.S. Push for Even Longer TPP Medicine Monopolies
Nov 062016
 

aftinettextlogo_0[AFTINet Press Release, Link] “The Australian government should reject the push from US Republican Congress members to increase biologic medicine monopolies by seven years, even more than the extra three years which has already been agreed in the TPP text,” Dr Patricia Ranald, Convener of the Australian Fair Trade and Investment Network said today. Continue reading »

Share

AARP, AFL-CIO, Oxfam, Consumers Union & MSF Letter to President Obama, re: Data Exclusivity for Biologics and the TPP

 Posted by on October 27, 2016  Comments Off on AARP, AFL-CIO, Oxfam, Consumers Union & MSF Letter to President Obama, re: Data Exclusivity for Biologics and the TPP
Oct 272016
 
Image:  EFF (CC-BY)

Image: EFF (CC-BY)

Click here for a printable PDF

Dear President Obama: As organizations that represent millions of Americans, including consumers, retirees, and patients, and that provide medical care globally, we are concerned about recent reports that your Administration is working behind the scenes to craft Trans-Pacific Partnership (TPP) implementing legislation and possibly enter into side letters that would  mean even more lengthy monopoly protections for biologics than the already onerous provisions in the TPP agreement. It is our understanding that this could bind the United States to a 12-year market exclusivity period for biologics and block the U.S. and other countries from reducing the amount of time expensive biologic drugs are protected from competition from less expensive biosimilar drugs. Continue reading »

Share

The Trans Pacific Partnership Agreement and Pharmaceutical Regulation in Canada and Australia

 Posted by on October 26, 2016  Comments Off on The Trans Pacific Partnership Agreement and Pharmaceutical Regulation in Canada and Australia
Oct 262016
 

lexchin-gleesonAuthors: Joel Lexchin and Deborah Gleeson

Abstract: The Trans Pacific Partnership Agreement (TPP) is a large regional trade agreement involving twelve countries. It was signed in principle in February 2016 but has not yet been ratified in any of the participating countries. The TPP provisions place a range of constraints on how governments regulate the pharmaceutical sector and set prices for medicines. Continue reading »

Share
Oct 172016
 

sean - 150x150Senior copyright industry experts described the Trans Pacific Partnership and other recent free trade agreements as likely setting a “high water mark” for intellectual property commitments in trade agreements. The statements came as part of a symposium last week on Trading in IP: Copyright Treaties and International Trade Agreements sponsored by Columbia Law School’s Kernochan Center for Law, Media, and the Arts.

Steve Metalitz, Partner at Mitchell, Silberberg & Knupp LLP and long-time Counsel to the International Intellectual Property Alliance, kicked off the discussion Continue reading »

Share

The Investment-Related Aspects of Intellectual Property Rights

 Posted by on September 27, 2016  Comments Off on The Investment-Related Aspects of Intellectual Property Rights
Sep 272016
 

yuAbstract: From the debate among presidential candidates on whether the United States should ratify the Trans-Pacific Partnership (TPP) Agreement to the arbitrations Philip Morris and Eli Lilly have sought through the investor-state dispute settlement (ISDS) mechanism, the investment-related aspects of intellectual property rights have recently garnered considerable policy, scholarly, and media attention.

This growing attention, to some extent, has brought back memories about the time when the WTO TRIPS Agreement began to transform intellectual property law by redirecting our focus to the trade-related aspects of intellectual property rights. Whether the recent developments on the investment front represent yet another paradigm shift in intellectual property law remains an important academic and policy question. Continue reading »

Share
Sep 142016
 

cato institute logoThe Cato Institute has released a report that “presents a chapter-by-chapter analysis of the Trans Pacific Partnership (TPP) from a free trader’s perspective.” It notes that TPP is really more of a “managed” or “freer” trade agreement than an agreement that really promotes “free trade” in a classic sense. It finds that overall, the “terms of the TPP are net liberalizing,” but that some of the individual chapters – including the intellectual property chapter – are actually “protectionist.” Continue reading »

Share

Briefing Note: Trading Away Health: The Trans-Pacific Partnership Agreement (TPP) – 2016

 Posted by on September 9, 2016  Comments Off on Briefing Note: Trading Away Health: The Trans-Pacific Partnership Agreement (TPP) – 2016
Sep 092016
 

msf big square croppedMedicins Sans Frontiers press release, Link

The Trans-Pacific Partnership (TPP) trade deal is currently under consideration by the US and eleven other Pacific Rim nations: Australia, Brunei Darussalam, Canada, Chile, Japan, Malaysia, Mexico, New Zealand, Peru, Singapore and Vietnam. The agreement is slated to further expand its membership, potentially to all 21 Asia Pacific APEC nations. Continue reading »

Share

The Trans Pacific Partnership Agreement and Pharmaceutical Regulation in Canada and Australia

 Posted by on August 19, 2016  Comments Off on The Trans Pacific Partnership Agreement and Pharmaceutical Regulation in Canada and Australia
Aug 192016
 

lexchin-gleesonAuthors: Joel Lexchin and Deborah Gleeson

Abstract: The Trans Pacific Partnership Agreement (TPP) is a large regional trade agreement involving 12 countries. It was signed in principle in February 2016 but has not yet been ratified in any of the participating countries. The TPP provisions place a range of constraints on how governments regulate the pharmaceutical sector and set prices for medicines. This article presents a prospective policy analysis of the possible effects of the TPP on these two points in Canada and Australia. Continue reading »

Share

Excerpt from Google’s Comments on New Zealand’s Trans Pacific Partnership Amendments Bill

 Posted by on August 17, 2016  Comments Off on Excerpt from Google’s Comments on New Zealand’s Trans Pacific Partnership Amendments Bill
Aug 172016
 

google_logo_largeThe New Zealand Parliamentary Committee on Foreign Affairs, Defence and Trade has posted draft legislation to bring its law into compliance with the Trans Pacific Partnership, as well comments on the legislation, all of which are available hereThe following excerpt from the comments submitted by Google New Zealand focuses on the importance of a “flexible and dynamic” copyright exception. 

Google believes that in order to promote innovation and creativity, New Zealand should adopt copyright exceptions that allow the market, new technologies and new creativity to evolve. New Zealand needs not only technologically neutral copyright protections, but also dynamic, technology neutral exceptions that allow new, legitimate uses of copyright and services to evolve as technology evolves. Continue reading »

Share

New Zealand Government Notice: Consultation on proposed patent term extension regulations

 Posted by on July 12, 2016  Comments Off on New Zealand Government Notice: Consultation on proposed patent term extension regulations
Jul 122016
 

nz flagMinistry of Business, Innovation, and Employment
Government of New Zealand

Submissions are due by 5pm on Monday, 8 August 2016
Consultation document (PDF)

On 11 July 2016, Ministry of Business, Innovation and Employment released a consultation document seeking feedback on proposed regulations to implement the patent term extension provisions in the Trans-Pacific Partnership Agreement Amendment Bill. The Bill will, when it enters into force, amend the Patents Act 2013 to provide for patent term extensions for:

  • Unreasonable delays in patent grant; and
  • Unreasonable curtailment of the effective patent term as a result of the Medsafe approval process.

Continue reading »

Share